Panoramic Capital’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
58,054
+20,000
+53% +$369K 0.88% 31
2025
Q4
$522K Buy
38,054
+2,058
+6% +$32.1K 0.28% 37
2025
Q3
$637K Buy
35,996
+9,635
+37% +$152K 0.29% 45
2025
Q2
$398K Sell
26,361
-26,362
-50% -$437K 0.3% 36
2025
Q1
$848K Buy
52,723
+4,152
+9% +$77.4K 0.98% 25
2024
Q4
$846K Buy
+48,571
New +$856K 0.45% 38

Other funds holding PLSE

Panoramic Capital's PLSE Position: Q1 2026 in Review

Panoramic Capital increased its Pulse Biosciences (PLSE) stake by 53% in Q1 2026, buying an estimated $369K and bringing the position to 58,054 shares worth $1.25M. The position accounts for 0.88% of the portfolio, ranked #31.

Panoramic Capital first reported a position in PLSE in Q4 2024 and has held it in 6 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Panoramic Capital held 58,054 shares of Pulse Biosciences worth $1.25M as of Q1 2026.
  • Panoramic Capital bought 20,000 Pulse Biosciences shares in Q1 2026, an estimated $369K.
  • Pulse Biosciences made up 0.88% of Panoramic Capital's portfolio in Q1 2026, its #31 holding.
  • Panoramic Capital first reported a position in Pulse Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Panoramic Capital's 13F filing for Q1 2026, filed 15 May 2026.